Ascendis Pharma A-S

Insider holdings at Ascendis Pharma show long‑term confidence, hinting at a rally if clinical milestones hit—an insider‑backed bullish outlook for investors.

Insider RSU activity shows Ascendis Pharma’s confidence in its once‑weekly growth‑hormone pipeline, signaling potential upside as clinical milestones near.